Clinical trial
Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)
NCT05915897 is registered in ClinicalTrials.gov with Sanguine Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)
- Lead sponsor
- Sanguine Biosciences
- Phase
- Observational
- Overall status
- Terminated
- Start date
- May 23, 2023
- Completion date
- March 25, 2024
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic granulomatous disease